Skip to main content

Advertisement

SpringerLink
Log in

Intrapartum Management of Moderate to Severe COVID-19: an Evidence-Based Update

  • REVIEW
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review was performed to provide an evidence-based approach to specific intrapartum management considerations for pregnant patients with moderate or severe COVID-19.

Recent Findings

Pregnant patients are at increased risk for serious illness related to COVID-19 infection including respiratory failure. Timing, mode, and location of delivery may be impacted by severe COVID-19 infection. The majority of medical therapies and other interventions are not contraindicated in the setting of COVID-19 infection and pregnancy.

Summary

Intrapartum management of pregnant women with moderate or severe COVID-19 infection requires a coordinated multidisciplinary effort with attention to delivery planning and adequate respiratory monitoring and support.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Huntley BJF, Huntly ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol. 2020;136(2):303–312.

  2. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Woodworth KR, Nahabedian JF 3rd, Azziz-Baumgartner E, Gilboa SM, Meaney-Delman D, CDC COVID-19 response pregnancy and infant linked outcomes team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–1647.

  3. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193:E540–8.

  4. Society of Maternal-Fetal Medicine, S.M.F.M. Management considerations for pregnant patients with COVID-19. Developed with guidance from Torre Halscott, MD, MS; Jason Vaught, MD; and the SMFM COVID-19 Task Force. 2021 [cited 2023 05–04–2023].

  5. • Nana M, HK, Lucas N, Camporota L, Knight M, Nelson-Piercy C. Diagnosis and management of covid-19 in pregnancy. BMJ. 2022;377:e069739. Systematic review Jan 2020-Dec 2021 summarizing evidence of epidemiology, phamacological and delivery management for pregnant patients with COVID-19.

  6. Tolcher MC, McKinney J, Eppes CS, Muigai D, Shamshirsaz A, Guntupalli KK, Nates JL. Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19). Obstet Gynecol, 2020;136(2):259–261.

  7. • Rose CH, Wyath M, Narang K, Lorenz KE, Szymanski LM, Vaught AJ. Timing of delivery with coronavirus disease 2019 pneumonia requiring intensive care unit admission. Am J Obstet Gynecol MFM. 2021;3(4):100373. Guidelines for pregnant patients with COVID-19 requiring ICU admission based on case reports, epidemiological data and the authors institutional experiences.

  8. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Accessed 6 March 2023; Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/pregnancy/.

  9. Resende MHF, YC, D'Souza R, Lapinsky SE, Nam A, Shah V, Whittle W, Wright JK, Naimark DMJ. Clinical decision analysis of elective delivery vs expectant management for pregnant individuals with COVID-19-related acute respiratory distress syndrome. Am J Obstet Gynecol MFM. 2022;4(6):100697.

  10. Slayton-Milam S, Sheffels S, Chan D, PharmD, BCPS (AQ-ID), Bashar Alkinj MD, Induction of labor in an intubated patient with coronavirus disease 2019 (COVID-19) Obstet Gynecol. 2020;136:962-4.

  11. Sichitiu J, Desseauve D. Intrapartum care of women with COVID-19: a practical approach. Eur J Obstet Gynecol Reprod Biol. 2020;24:94-95.

  12. Khoury R, BP, Debolt C, Stone J, Sutton DM, Simpson LL, Limaye MA, Roman AS, Fazzari M, Penfield CA, Ferrara L, Lambert C, Nathan L, Wright R, Bianco A, Wagner B, Goffman D, Gyamfi-Bannerman C, Schweizer WE, Avila K, Khaksari B, Proehl M, Heitor F, Monro J, Keefe DL, D'Alton ME, Brodman M, Makhija SK, Dolan SM. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City Medical Centers. . Obstet Gynecol. 2020;136(2):273–282.

  13. Gale C, QM, Placzek A et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc Health. 2021;5:113–21.

  14. Walker KF, O.D.K., Grace N, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020;127:1324–36.

  15. Ann McHugh MAE-K MD, Neidin Bussmann MD, Anne Doherty MD, Orla Franklin MD, Fionnuala Breathnach M. Hyperoxygenation in pregnancy exerts a more profound effect on cardiovascular hemodynamics than is observed in the nonpregnant state. Am J Obstet Gynecol. 2019;(4):397e.1–397.e8.

  16. Pacheco LD, Saad A, Saade G. Early acute respiratory support for pregnant patients with coronavirus disease 2019 (COVID-19) infection. Obstet Gynecol. 2020;136(1):42–45.

  17. • Eid J, Stahl D, Costantine MM, Rood KM. Oxygen saturation in pregnant individuals with COVID-19: time for re-appraisal? Am J Obstet Gynecol. 2022;226(6):813–6. Critical review of evidence for oxygen saturation goal of > 95% in pregnancy.

  18. Zhou S, Zhou Y, Cao X, Ni X, Du W, Xu Z, Liu Z. The efficacy of high flow nasal oxygenation for maintaining maternal oxygenation during rapid sequence induction in pregnancy: a prospective randomised clinical trial. Eur J Anaesthesiol. 2021;38(10):1052–1058.

  19. Ni YN, LJ, Yu H, Liu D, Ni Z, Cheng J, Liang BM, Liang ZA. Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation?: a systematic review and meta-analysis. Chest. 2017;151(4):764–775.

  20. Thuresson S, Fraenkel C, Sasinovich S, Soldemyr J, Widell A, Medstrand P, Alsved M, Löndahl J. Airborne severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospitals: effects of aerosol-generating procedures, HEPA-filtration units, patient viral load, and physical distance. Clin Infect Dis. 2022;75(1):e89-e96.

  21. Safaee Fakhr B, W.S., Pinciroli R, Gianni S, Morais CCA, Ikeda T, Miyazaki Y, Marutani E, Di Fenza R, Larson GM, Parcha V, Gibson LE, Chang MG, Arora P, Carroll RW, Kacmarek RM, Ichinose F, Barth WH Jr, Kaimal A, Hohmann El, Zapol WM, Berra L. High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronovirus disease 2019 (COVID-19). Obstet Gynecol. 2020;136(6):1109–1113.

  22. Valsecchi C, WD, Safaee Fakhr B, Collier AY, Nozari A, Ortoleva J, Mukerji S, Gibson LE, Carroll RW, Shaefi S, Pinciroli R, La Vita C, Ackman JB, Hohmann E, Arora P, Barth WH Jr, Kaimal A, Ichinose F, Berra L; DELiverly oF iNO (DELFiNO) Network Collaborators. High-dose inhaled nitric oxide for the treatment of spontaneously breathing pregnant patients with severe coronavirus disease 2019 (COVID-19) pneumonia. Obstet Gynecol. 2022;140(2):195–203.

  23. D'Souza R, Ashraf R, Rowe H, Zipursky J, Clarfield L, Maxwell C, Arzola C, Lapinsky S, Paquette K, Murthy S, Cheng MP, Malhamé I. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol. 2021;57(2):195–203.

  24. Roberts D, BJ, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.

  25. Wagner C, GM, Mikolajewska A, Mueller A, Nothacker M, Kley K, Metzendorf MI, Fischer AL, Kopp M, Stegemann M, Skoetz N, Fichtner F, Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;8(8).

  26. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81(5):936–45.

  27. RECOVERY Collaborative Group; Horby P, Lim W, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704.

  28. Akinosoglou K, Schinas G, Rigopoulos EA, Polyzou E, Tzouvelekis A, Adonakis G, Gogos C. COVID-19 pharmacotherapy in pregnancy: a literature review of current therapeutic choices. Viruses. 2023;15(3):787.

  29. Crowther CA, MC, Middleton P, Harding JE., Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015(7).

  30. Bain ES, Middleton P, Crowther CA, Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. 2013;13:195.

  31. Zahar AZ, Azny M, Sakinah A, Gayathiri M, Terbutaline for acute tocolysis prior to emergency caesarean delivery for suspected foetal compromise. Med J Malaysia. 2023;78(1):93–97.

  32. ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-e52.

  33. Reese JT, CB, Chan L, Blau H, Callahan TJ, Cappelletti L, Fontana T, Bradwell KR, Harris NL, Casiraghi E, Valentini G, Karlebach G, Deer R, McMurry JA, Haendel MA, Chute CG, Pfaff E, Moffitt R, Spratt H, Singh JA, Mungall CJ, Williams AE, Robinson PN. NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study. Virol J. 2022;19(1):84.

  34. Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M., Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic. . Ultrasound Obstet Gynecol. 2020;55(6):841–843.

  35. Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Ann Rheum Dis. 2021;80(2):e12.

  36. Marazzit D, Buemann B. Kerstin Unvas-Moberg, Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients? The World Journal of Biological Psychiatry 2021;22(5):387-398.

  37. Pérez-López FR, Savirón-Cornudella R, Chedraui P, López-Baena MT, Pérez-Roncero G, Sanz-Arenal A, Narváez-Salazar M, Dieste-Pérez P, Tajada M. Obstetric and perinatal outcomes of pregnancies with COVID 19: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022;35(25):9742–9758.

  38. Guo Q, Zhao D, Dong F, Liu S, Chen Y, Jin J, Fraidenburg DR, Huang JA. Delivery of fetus death with misoprostol in a pregnant woman with H7N9 avian influenza A virus pneumonia and ARDS. Crit Care. 2014;18(5):589.

  39. Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(1):68–89.

  40. Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: current evidence and perspectives. High Blood Press Cardiovasc Prev. 2022;29(2):115–123.

  41. Hirshberg A, Srinivas S. Epidemiology of maternal morbidity and mortality. Semin Perinatol. 2017;41(6):332–337.

  42. Pucci M, SN, Knox E, Lipkin G, Martin U. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits. Expert Rev Clin Pharmacol. 2015;8(2):221–31.

  43. • Farhan FS, Nori W. Israa Talib Abd Al Kadir,Ban Hadi Hameed, Can fetal heart lie? Intrapartum CTG changes in COVID‑19 mothers. J Obst Gynecol India. 2022;72(6):479–84. Case control study of CTG intrapartum changes in COVID-19 patients.

  44. Lee LO, Bateman B, Kheterpal S, Klumpner TT, Housey M, Aziz MF, Hand KW, MacEachern M, Goodier CG, Bernstein J, Bauer ME. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2017;126:1053–1063.

  45. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N, Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002.

  46. D’Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020;99(9):1110–1120.

  47. Chmielewska B, BI, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, O'Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Ladhani S, von Dadelszen P, Magee L, Khalil A. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):e759-e772.

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Baylor College of Medicine, Houston, USA

    Kelly Albrecht & Mary Catherine Tolcher

Authors
  1. Kelly Albrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Catherine Tolcher
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.A. and M.C.T drafted an outline for the manuscript. K.A. wrote a draft of the main manuscript. M.C.T. edited heavily and added content. M.C.T. wrote the abstract. Both authors reviewed the manuscript.

Corresponding author

Correspondence to Mary Catherine Tolcher.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albrecht, K., Tolcher, M.C. Intrapartum Management of Moderate to Severe COVID-19: an Evidence-Based Update. Curr Obstet Gynecol Rep 12, 165–172 (2023). https://doi.org/10.1007/s13669-023-00368-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-023-00368-5

Keywords

Search

Navigation